Connor, Clark & Lunn Investment Management (CC&L)’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.3M | Buy |
248,633
+192,768
| +345% | +$24.2M | 0.11% | 165 |
|
|
2025
Q1 | $6.18M | Sell |
55,865
-7,717
| -12% | -$854K | 0.03% | 448 |
|
|
2024
Q4 | $8.68M | Buy |
63,582
+46,396
| +270% | +$6.33M | 0.04% | 357 |
|
|
2024
Q3 | $1.98M | Buy |
17,186
+14,956
| +671% | +$1.72M | 0.01% | 673 |
|
|
2024
Q2 | $307K | Buy |
+2,230
| New | +$307K | ﹤0.01% | 1180 |
|
|
2024
Q1 | – | Sell |
-27,921
| Closed | -$3.68M | – | 1657 |
|
|
2023
Q4 | $3.68M | Sell |
27,921
-42,148
| -60% | -$5.55M | 0.02% | 512 |
|
|
2023
Q3 | $7.88M | Sell |
70,069
-92,200
| -57% | -$10.4M | 0.04% | 287 |
|
|
2023
Q2 | $15.3M | Sell |
162,269
-78,947
| -33% | -$7.44M | 0.08% | 194 |
|
|
2023
Q1 | $24.4M | Buy |
241,216
+64,612
| +37% | +$6.54M | 0.13% | 132 |
|
|
2022
Q4 | $21.1M | Sell |
176,604
-20,704
| -10% | -$2.47M | 0.12% | 134 |
|
|
2022
Q3 | $21M | Sell |
197,308
-17,389
| -8% | -$1.85M | 0.14% | 117 |
|
|
2022
Q2 | $20.9M | Buy |
214,697
+5,098
| +2% | +$497K | 0.13% | 125 |
|
|
2022
Q1 | $19.7M | Buy |
209,599
+157,512
| +302% | +$14.8M | 0.1% | 157 |
|
|
2021
Q4 | $4.44M | Buy |
+52,087
| New | +$4.44M | 0.02% | 356 |
|
|
2021
Q2 | – | Sell |
-4,586
| Closed | -$446K | – | 1057 |
|
|
2021
Q1 | $446K | Buy |
+4,586
| New | +$446K | ﹤0.01% | 806 |
|
|
2020
Q4 | – | Sell |
-10,499
| Closed | -$1.01M | – | 996 |
|
|
2020
Q3 | $1.01M | Buy |
+10,499
| New | +$1.01M | 0.01% | 621 |
|
|
2018
Q4 | – | Sell |
-2,975
| Closed | -$366K | – | 1012 |
|
|
2018
Q3 | $366K | Buy |
+2,975
| New | +$366K | ﹤0.01% | 755 |
|
|
2015
Q2 | – | Sell |
-35,500
| Closed | -$1.41M | – | 647 |
|
|
2015
Q1 | $1.41M | Sell |
35,500
-10,400
| -23% | -$413K | 0.01% | 270 |
|
|
2014
Q4 | $1.03M | Buy |
+45,900
| New | +$1.03M | 0.01% | 304 |
|
|
2014
Q1 | – | Sell |
-36,700
| Closed | -$364K | – | 743 |
|
|
2013
Q4 | $364K | Sell |
36,700
-55,600
| -60% | -$551K | ﹤0.01% | 558 |
|
|
2013
Q3 | $1.07M | Buy |
92,300
+67,300
| +269% | +$783K | 0.01% | 263 |
|
|
2013
Q2 | $353K | Buy |
+25,000
| New | +$353K | ﹤0.01% | 407 |
|